Clinical Trial Update: Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan [Phase 3]

View source ↗

Summary

This clinical trial update covers rilzabrutinib for adults with immune thrombocytopenia. It notes that a Phase 3 study conducted in Japan has been completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Rilzabrutinib (rilzabrutinib)

Snippet

Sponsor: Sanofi | Conditions: Immune Thrombocytopenia | Phase 3 | Status: ACTIVE_NOT_RECRUITING